Skip to main content
Premium Trial:

Request an Annual Quote

Aperiomics Wins $737K Phase II NSF Grant

NEW YORK (GenomeWeb) – Aperiomics has received an approximately $737,000 Phase II Small Business Innovation Research grant from the National Science Foundation's Small Business Innovation Research program to further develop its next-generation sequencing data analytics for infectious diseases.

Sterling, VA-based Aperiomics offers commercial sequencing and bioinformatics-based services for detecting known and unknown pathogens and characterizing microorganisms in animal and human samples. It provides services to customers in markets such as animal monitoring, agricultural testing, and human diagnostics.

Aperiomics specifically plans to use the new round of funding to improve its viral detection capabilities, develop new functionalities, and develop an integrated web-based interface for its system, according to the grant abstract.

The current grant follows two earlier Phase I and Phase Ib feasibility grants from the NSF. The new award brings Aperiomics' total funding from the program to nearly $1 million.